Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft-versus-host disease.
Br J Dermatol
; 177(5): e206-e208, 2017 11.
Article
in En
| MEDLINE
| ID: mdl-28422274
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazoles
/
Scleroderma, Localized
/
Dermatologic Agents
/
Graft vs Host Disease
Type of study:
Observational_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Br J Dermatol
Year:
2017
Document type:
Article